Clinical Trials Browser

Phase 1/2 × Mesothelioma × Drug Therapy × Clear all

NCT07131345 2025-08-20

Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma

Phase 1/2 Not yet recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma